Each N-PORT filing of PPH compared with the one before: positions added and dropped, the largest weight changes, turnover. Computed by Mulden from the filings; dated by filing period and SEC receipt.https://themulden.com/enhttps://themulden.com/funds/pph/https://themulden.com/funds/pph/25 positions became 25: 0 added (0% of the fund), 0 dropped (0%). Turnover proxy 4.2%. Largest increases: Eli Lilly & Co 18.76% to 20.33%; Novo Nordisk A/S 4.83% to 5.39%; AbbVie Inc 4.13% to 4.6%; Corcept Therapeutics Inc 0.22% to 0.51%; Jazz Pharmaceuticals PLC 0.8% to 1.09%; Axsome Therapeutics Inc 0.52% to 0.77%. Largest decreases: Zoetis Inc 3.49% to 2.11%; Sanofi SA 4.74% to 4.02%; Pfizer Inc 5.24% to 4.53%; Cencora Inc 3.75% to 3.37%; Takeda Pharmaceutical Co Ltd 3.16% to 2.89%; GSK PLC 4.59% to 4.44%. Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Wed, 26 Aug 2026 12:00:00 GMThttps://themulden.com/funds/pph/https://themulden.com/funds/pph/25 positions became 25: 1 added (4.41% of the fund), 1 dropped (4.35%). Turnover proxy 8.7%. Largest increases: Merck & Co Inc 8.9% to 9.71%; Novartis AG 10.05% to 10.8%; Pfizer Inc 4.64% to 5.24%; Takeda Pharmaceutical Co Ltd 2.58% to 3.16%; Sanofi SA 4.35% to 4.74%; Teva Pharmaceutical Industries Ltd 2.61% to 2.84%. Largest decreases: Eli Lilly & Co 20.8% to 18.76%; Novo Nordisk A/S 6.45% to 4.83%; AbbVie Inc 4.39% to 4.13%; Cencora Inc 3.97% to 3.75%; McKesson Corp 4.37% to 4.25%; Elanco Animal Health Inc 0.43% to 0.35%. New: AstraZeneca PLC (4.41%). Gone: AstraZeneca PLC (4.35%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Thu, 28 May 2026 12:00:00 GMThttps://themulden.com/funds/pph/https://themulden.com/funds/pph/25 positions became 25: 0 added (0% of the fund), 0 dropped (0%). Turnover proxy 4.7%. Largest increases: Merck & Co Inc 7.44% to 8.9%; Eli Lilly & Co 19.92% to 20.8%; Teva Pharmaceutical Industries Ltd 1.77% to 2.61%; Bristol-Myers Squibb Co 4.24% to 4.56%; Novartis AG 9.73% to 10.05%; Cencora Inc 3.69% to 3.97%. Largest decreases: Novo Nordisk A/S 7.74% to 6.45%; Zoetis Inc 4.34% to 3.48%; McKesson Corp 4.85% to 4.37%; Pfizer Inc 5.11% to 4.64%; AbbVie Inc 4.85% to 4.39%; GSK PLC 4.72% to 4.38%. Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Fri, 27 Feb 2026 12:00:00 GMThttps://themulden.com/funds/pph/https://themulden.com/funds/pph/24 positions became 25: 1 added (0.42% of the fund), 0 dropped (0%). Turnover proxy 7.2%. Largest increases: Novartis AG 7.65% to 9.73%; Merck & Co Inc 5.88% to 7.44%; Eli Lilly & Co 18.65% to 19.92%; Pfizer Inc 4.6% to 5.11%; GSK PLC 4.29% to 4.72%; AbbVie Inc 4.51% to 4.85%. Largest decreases: Johnson & Johnson 10.07% to 4.68%; Haleon PLC 3.68% to 2.91%; Takeda Pharmaceutical Co Ltd 2.99% to 2.61%; Cencora Inc 3.9% to 3.69%; AstraZeneca PLC 4.41% to 4.21%; Sanofi SA 4.52% to 4.44%. New: Corcept Therapeutics Inc (0.42%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Fri, 21 Nov 2025 12:00:00 GMThttps://themulden.com/funds/pph/https://themulden.com/funds/pph/25 positions became 24: 0 added (0% of the fund), 1 dropped (0.57%). Turnover proxy 16.8%. Largest increases: Eli Lilly & Co 11.89% to 18.65%; Johnson & Johnson 6.67% to 10.07%; Novo Nordisk A/S 4.67% to 7.59%; Novartis AG 5.16% to 7.65%; Merck & Co Inc 4.83% to 5.88%; Pfizer Inc 4.46% to 4.6%. Largest decreases: Teva Pharmaceutical Industries Ltd 4.22% to 1.6%; AbbVie Inc 6.66% to 4.51%; Viatris Inc 2.31% to 0.66%; Takeda Pharmaceutical Co Ltd 4.5% to 2.99%; Jazz Pharmaceuticals PLC 1.92% to 0.47%; Cencora Inc 4.95% to 3.9%. Gone: Patterson Cos Inc (0.57%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Thu, 21 Aug 2025 12:00:00 GMThttps://themulden.com/funds/pph/https://themulden.com/funds/pph/24 positions became 25: 1 added (1.1% of the fund), 0 dropped (0%). Turnover proxy 5.3%. Largest increases: Jazz Pharmaceuticals PLC 0.99% to 1.92%; Perrigo Co PLC 0.41% to 0.9%; Elanco Animal Health Inc 0.56% to 1.04%; Organon & Co 0.5% to 0.93%; Cencora Inc 4.53% to 4.95%; Viatris Inc 1.9% to 2.31%. Largest decreases: Novo Nordisk A/S 6.68% to 4.67%; Eli Lilly & Co 13.35% to 11.89%; Merck & Co Inc 5.37% to 4.83%; Pfizer Inc 4.92% to 4.46%; Johnson & Johnson 6.98% to 6.67%; AstraZeneca PLC 5.05% to 4.89%. New: Axsome Therapeutics Inc (1.1%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Tue, 27 May 2025 12:00:00 GMThttps://themulden.com/funds/pph/https://themulden.com/funds/pph/25 positions became 24: 0 added (0% of the fund), 1 dropped (1.07%). Turnover proxy 3.9%. Largest increases: Teva Pharmaceutical Industries Ltd 3.64% to 4.26%; AbbVie Inc 6.24% to 6.78%; Eli Lilly & Co 12.85% to 13.35%; Pfizer Inc 4.49% to 4.92%; Johnson & Johnson 6.55% to 6.98%; GSK PLC 4.29% to 4.59%. Largest decreases: Novo Nordisk A/S 8.36% to 6.68%; Zoetis Inc 4.73% to 4.3%; Bristol-Myers Squibb Co 4.9% to 4.67%; Organon & Co 0.66% to 0.5%; Haleon PLC 4.66% to 4.57%; Bausch Health Cos Inc 0.4% to 0.3%. Gone: Catalent Inc (1.07%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Wed, 26 Feb 2025 12:00:00 GMThttps://themulden.com/funds/pph/https://themulden.com/funds/pph/25 positions became 25: 0 added (0% of the fund), 0 dropped (0%). Turnover proxy 3.2%. Largest increases: AbbVie Inc 5.56% to 6.24%; Johnson & Johnson 5.99% to 6.55%; Bristol-Myers Squibb Co 4.44% to 4.9%; Teva Pharmaceutical Industries Ltd 3.29% to 3.64%; Catalent Inc 0.79% to 1.07%; Zoetis Inc 4.47% to 4.73%. Largest decreases: Novo Nordisk A/S 10.17% to 8.36%; Merck & Co Inc 5.69% to 5.15%; Eli Lilly & Co 13.32% to 12.85%; Pfizer Inc 4.58% to 4.49%; Elanco Animal Health Inc 0.73% to 0.65%; McKesson Corp 4.53% to 4.45%. Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Tue, 19 Nov 2024 12:00:00 GMThttps://themulden.com/funds/pph/https://themulden.com/funds/pph/25 positions became 25: 0 added (0% of the fund), 0 dropped (0%). Turnover proxy 3.8%. Largest increases: Eli Lilly & Co 11.78% to 13.32%; Novo Nordisk A/S 9.44% to 10.17%; Teva Pharmaceutical Industries Ltd 2.8% to 3.29%; Novartis AG 4.72% to 5.08%; Zoetis Inc 4.11% to 4.47%; Takeda Pharmaceutical Co Ltd 4.22% to 4.4%. Largest decreases: Johnson & Johnson 6.68% to 5.99%; Merck & Co Inc 6.24% to 5.69%; AbbVie Inc 6.08% to 5.56%; Viatris Inc 1.85% to 1.6%; GSK PLC 4.49% to 4.24%; AstraZeneca PLC 5.15% to 4.9%. Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Tue, 20 Aug 2024 12:00:00 GMThttps://themulden.com/funds/pph/https://themulden.com/funds/pph/25 positions became 25: 0 added (0% of the fund), 0 dropped (0%). Turnover proxy 6.6%. Largest increases: Eli Lilly & Co 9.13% to 11.78%; Novo Nordisk A/S 7.87% to 9.44%; Merck & Co Inc 5.34% to 6.24%; AbbVie Inc 5.35% to 6.08%; Cencora Inc 4.43% to 4.62%; McKesson Corp 4.37% to 4.56%. Largest decreases: Jazz Pharmaceuticals PLC 2.21% to 1.09%; Viatris Inc 2.88% to 1.85%; Teva Pharmaceutical Industries Ltd 3.71% to 2.8%; Zoetis Inc 4.69% to 4.11%; Elanco Animal Health Inc 1.47% to 0.94%; Catalent Inc 1.36% to 0.93%. Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Tue, 28 May 2024 12:00:00 GMThttps://themulden.com/funds/pph/https://themulden.com/funds/pph/25 positions became 25: 0 added (0% of the fund), 0 dropped (0%). Turnover proxy 5.6%. Largest increases: Novo Nordisk A/S 5.79% to 7.87%; Eli Lilly & Co 7.52% to 9.13%; Johnson & Johnson 6.07% to 6.67%; Merck & Co Inc 4.86% to 5.34%; Zoetis Inc 4.21% to 4.69%; AbbVie Inc 5.14% to 5.35%. Largest decreases: Viatris Inc 3.69% to 2.88%; Teva Pharmaceutical Industries Ltd 4.45% to 3.71%; Catalent Inc 1.85% to 1.36%; Sanofi SA 5.12% to 4.68%; Haleon PLC 4.8% to 4.38%; McKesson Corp 4.78% to 4.37%. Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Thu, 22 Feb 2024 12:00:00 GMThttps://themulden.com/funds/pph/https://themulden.com/funds/pph/25 positions became 25: 0 added (0% of the fund), 0 dropped (0%). Turnover proxy 6.5%. Largest increases: Eli Lilly & Co 5.21% to 7.52%; Johnson & Johnson 5.06% to 6.07%; Novo Nordisk A/S 4.98% to 5.79%; AbbVie Inc 4.78% to 5.14%; Takeda Pharmaceutical Co Ltd 4.26% to 4.61%; AstraZeneca PLC 4.73% to 5.08%. Largest decreases: Jazz Pharmaceuticals PLC 3.56% to 2.55%; Organon & Co 2.11% to 1.23%; Viatris Inc 4.48% to 3.69%; Catalent Inc 2.54% to 1.85%; Perrigo Co PLC 1.88% to 1.23%; Patterson Cos Inc 1.29% to 0.77%. Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Wed, 15 Nov 2023 12:00:00 GMThttps://themulden.com/funds/pph/https://themulden.com/funds/pph/25 positions became 25: 0 added (0% of the fund), 0 dropped (0%). Turnover proxy 7.3%. Largest increases: Viatris Inc 3.17% to 4.48%; Teva Pharmaceutical Industries Ltd 3.17% to 4.26%; Jazz Pharmaceuticals PLC 2.59% to 3.56%; Elanco Animal Health Inc 0.93% to 1.7%; Patterson Cos Inc 0.61% to 1.29%; Perrigo Co PLC 1.28% to 1.88%. Largest decreases: Johnson & Johnson 7.61% to 5.06%; Novo Nordisk A/S 6.23% to 4.98%; AbbVie Inc 5.72% to 4.78%; AstraZeneca PLC 5.22% to 4.73%; Novartis AG 5.33% to 4.97%; Pfizer Inc 4.91% to 4.57%. Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Wed, 16 Aug 2023 12:00:00 GMThttps://themulden.com/funds/pph/https://themulden.com/funds/pph/25 positions became 25: 0 added (0% of the fund), 0 dropped (0%). Turnover proxy 4.4%. Largest increases: Novo Nordisk A/S 5.37% to 6.23%; Catalent Inc 2.03% to 2.74%; Bristol-Myers Squibb Co 4.48% to 4.97%; Sanofi 4.52% to 5%; Novartis AG 4.92% to 5.33%; GSK PLC 4.26% to 4.6%. Largest decreases: Viatris Inc 4.29% to 3.17%; Johnson & Johnson 8.25% to 7.61%; Organon & Co 2.17% to 1.69%; Jazz Pharmaceuticals PLC 2.99% to 2.59%; Teva Pharmaceutical Industries Ltd 3.54% to 3.17%; Haleon PLC 4.9% to 4.54%. Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Tue, 30 May 2023 12:00:00 GMThttps://themulden.com/funds/pph/https://themulden.com/funds/pph/25 positions became 25: 0 added (0% of the fund), 0 dropped (0%). Turnover proxy 3.9%. Largest increases: Viatris Inc 3.22% to 4.29%; Jazz Pharmaceuticals PLC 2.41% to 2.99%; Teva Pharmaceutical Industries Ltd 3% to 3.54%; Novo Nordisk A/S 5.01% to 5.37%; Organon & Co 1.85% to 2.17%; Merck & Co Inc 5.23% to 5.41%. Largest decreases: Johnson & Johnson 9.29% to 8.25%; Bristol-Myers Squibb Co 5.45% to 4.48%; Catalent Inc 2.87% to 2.03%; Eli Lilly & Co 5.88% to 5.49%; Pfizer Inc 5.38% to 5.07%; GSK PLC 4.44% to 4.26%. Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Mon, 27 Feb 2023 12:00:00 GMThttps://themulden.com/funds/pph/https://themulden.com/funds/pph/25 positions became 25: 2 added (9.38% of the fund), 2 dropped (4.8%). Turnover proxy 15.1%. Largest increases: Johnson & Johnson 5.13% to 9.29%; Eli Lilly & Co 5.3% to 5.88%; Pfizer Inc 5.02% to 5.38%; Bristol-Myers Squibb Co 5.18% to 5.45%; AbbVie Inc 5.25% to 5.52%; Novo Nordisk A/S 4.92% to 5.01%. Largest decreases: Organon & Co 3.51% to 1.85%; Catalent Inc 4.46% to 2.87%; Elanco Animal Health Inc 2.51% to 1.12%; Jazz Pharmaceuticals PLC 3.65% to 2.41%; Viatris Inc 4.07% to 3.22%; Teva Pharmaceutical Industries Ltd 3.68% to 3%. New: Haleon PLC (4.94%), GSK PLC (4.44%). Gone: GSK PLC (4.54%), Amarin Corp PLC (0.26%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Mon, 28 Nov 2022 12:00:00 GMThttps://themulden.com/funds/pph/https://themulden.com/funds/pph/25 positions became 25: 0 added (0% of the fund), 0 dropped (0%). Turnover proxy 3.4%. Largest increases: Jazz Pharmaceuticals PLC 3.03% to 3.65%; Takeda Pharmaceutical Co Ltd 4.24% to 4.77%; Organon & Co 3.01% to 3.51%; Zoetis Inc 4.24% to 4.62%; Perrigo Co PLC 1.45% to 1.72%; Merck & Co Inc 5% to 5.22%. Largest decreases: Bausch Health Cos Inc 2.66% to 1.09%; Elanco Animal Health Inc 2.97% to 2.51%; Viatris Inc 4.48% to 4.07%; Catalent Inc 4.78% to 4.46%; Amarin Corp PLC 0.5% to 0.26%; Novartis AG 5.06% to 4.95%. Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Wed, 24 Aug 2022 12:00:00 GMThttps://themulden.com/funds/pph/https://themulden.com/funds/pph/25 positions became 25: 0 added (0% of the fund), 0 dropped (0%). Turnover proxy 2.6%. Largest increases: Jazz Pharmaceuticals PLC 2.53% to 3.03%; Catalent Inc 4.29% to 4.78%; Teva Pharmaceutical Industries Ltd 3.36% to 3.78%; Novo Nordisk A/S 4.69% to 5.01%; Organon & Co 2.73% to 3.01%; AstraZeneca PLC 5.01% to 5.2%. Largest decreases: Bausch Health Cos Inc 3.13% to 2.66%; Pfizer Inc 5.45% to 5.03%; Elanco Animal Health Inc 3.3% to 2.97%; Zoetis Inc 4.54% to 4.24%; Sanofi 4.95% to 4.69%; Eli Lilly & Co 5.37% to 5.16%. Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Fri, 27 May 2022 12:00:00 GMThttps://themulden.com/funds/pph/https://themulden.com/funds/pph/25 positions became 25: 0 added (0% of the fund), 0 dropped (0%). Turnover proxy 3.1%. Largest increases: Eli Lilly & Co 4.74% to 5.37%; Pfizer Inc 4.83% to 5.45%; Bristol-Myers Squibb Co 4.76% to 5.14%; Viatris Inc 4.38% to 4.65%; Novartis AG 4.88% to 5.1%; AmerisourceBergen Corp 4.52% to 4.7%. Largest decreases: Teva Pharmaceutical Industries Ltd 3.86% to 3.36%; AstraZeneca PLC 5.5% to 5.01%; Perrigo Co PLC 1.76% to 1.41%; Novo Nordisk A/S 4.98% to 4.69%; Organon & Co 3.02% to 2.73%; Takeda Pharmaceutical Co Ltd 4.49% to 4.22%. Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Fri, 25 Feb 2022 12:00:00 GMThttps://themulden.com/funds/pph/https://themulden.com/funds/pph/25 positions became 25: 0 added (0% of the fund), 0 dropped (0%). Turnover proxy 2.2%. Largest increases: Organon & Co 2.4% to 3.02%; Teva Pharmaceutical Industries Ltd 3.56% to 3.86%; AstraZeneca PLC 5.22% to 5.5%; Perrigo Co PLC 1.55% to 1.76%; Viatris Inc 4.18% to 4.38%; Amarin Corp PLC 0.6% to 0.77%. Largest decreases: Jazz Pharmaceuticals PLC 2.95% to 2.41%; Zoetis Inc 4.76% to 4.36%; Bristol-Myers Squibb Co 5.12% to 4.76%; Eli Lilly & Co 5.09% to 4.74%; GlaxoSmithKline PLC 4.54% to 4.43%; Pfizer Inc 4.93% to 4.83%. Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Mon, 22 Nov 2021 12:00:00 GMThttps://themulden.com/funds/pph/https://themulden.com/funds/pph/25 positions became 25: 1 added (2.4% of the fund), 1 dropped (1.68%). Turnover proxy 4.7%. Largest increases: Eli Lilly & Co 4.52% to 5.09%; Elanco Animal Health Inc 3.11% to 3.55%; Novo Nordisk A/S 4.68% to 5.03%; AstraZeneca PLC 4.97% to 5.22%; Jazz Pharmaceuticals PLC 2.72% to 2.95%; Merck & Co Inc 5.13% to 5.27%. Largest decreases: Bausch Health Cos Inc 3.9% to 3.06%; Teva Pharmaceutical Industries Ltd 4.02% to 3.56%; AmerisourceBergen Corp 4.73% to 4.4%; Viatris Inc 4.45% to 4.18%; Amarin Corp PLC 0.87% to 0.6%; McKesson Corp 4.76% to 4.53%. New: Organon & Co (2.4%). Gone: GW Pharmaceuticals PLC (1.68%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Fri, 27 Aug 2021 12:00:00 GMThttps://themulden.com/funds/pph/https://themulden.com/funds/pph/25 positions became 25: 0 added (0% of the fund), 0 dropped (0%). Turnover proxy 4.7%. Largest increases: Bausch Health Cos Inc 3.01% to 3.9%; Pfizer Inc 4.4% to 5.16%; GW Pharmaceuticals PLC 0.97% to 1.68%; Elanco Animal Health Inc 2.59% to 3.11%; McKesson Corp 4.38% to 4.76%; AmerisourceBergen Corp 4.35% to 4.73%. Largest decreases: Jazz Pharmaceuticals PLC 3.89% to 2.72%; Eli Lilly and Co 5.34% to 4.52%; Catalent Inc 5.07% to 4.29%; Perrigo Co PLC 2.22% to 1.44%; Viatris Inc 4.81% to 4.45%; Novo Nordisk A/S 4.97% to 4.68%. Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Fri, 28 May 2021 12:00:00 GMThttps://themulden.com/funds/pph/https://themulden.com/funds/pph/25 positions became 25: 1 added (4.81% of the fund), 1 dropped (3.43%). Turnover proxy 7%. Largest increases: Bausch Health Cos Inc 2.36% to 3.01%; Catalent Inc 4.58% to 5.07%; Eli Lilly and Co 4.91% to 5.34%; Novartis AG 4.96% to 5.16%; Johnson & Johnson 5.01% to 5.14%; AbbVie Inc 4.81% to 4.93%. Largest decreases: Pfizer Inc 5.11% to 4.4%; Elanco Animal Health Inc 3.16% to 2.59%; Teva Pharmaceutical Industries Ltd 4.6% to 4.08%; AstraZeneca PLC 5.14% to 4.63%; Perrigo Co PLC 2.68% to 2.22%; Novo Nordisk A/S 5.25% to 4.97%. New: Viatris Inc (4.81%). Gone: Mylan NV (3.43%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Tue, 23 Feb 2021 12:00:00 GMThttps://themulden.com/funds/pph/https://themulden.com/funds/pph/25 positions became 25: 0 added (0% of the fund), 0 dropped (0%). Turnover proxy 4.4%. Largest increases: Jazz Pharmaceuticals PLC 2.73% to 3.95%; Catalent Inc 3.7% to 4.58%; Novo Nordisk A/S 4.5% to 5.25%; Pfizer Inc 4.63% to 5.11%; Zoetis Inc 4.48% to 4.72%; Johnson & Johnson 4.84% to 5.01%. Largest decreases: GW Pharmaceuticals PLC 1.7% to 0.99%; Bausch Health Cos Inc 3.06% to 2.36%; Eli Lilly and Co 5.53% to 4.91%; GlaxoSmithKline PLC 4.89% to 4.29%; Amarin Corp PLC 1.42% to 0.98%; AbbVie Inc 5.15% to 4.81%. Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Wed, 25 Nov 2020 12:00:00 GMThttps://themulden.com/funds/pph/https://themulden.com/funds/pph/25 positions became 25: 0 added (0% of the fund), 0 dropped (0%). Turnover proxy 3.7%. Largest increases: Catalent Inc 2.91% to 3.7%; Amarin Corp PLC 0.85% to 1.42%; AbbVie Inc 4.68% to 5.15%; Sanofi 4.58% to 5.04%; Eli Lilly and Co 5.16% to 5.53%; GW Pharmaceuticals PLC 1.43% to 1.7%. Largest decreases: Novo Nordisk A/S 5.42% to 4.5%; Pfizer Inc 5.28% to 4.63%; Johnson & Johnson 5.18% to 4.84%; Merck & Co Inc 5.06% to 4.81%; Elanco Animal Health Inc 3.53% to 3.29%; Mylan NV 3.61% to 3.39%. Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Thu, 27 Aug 2020 12:00:00 GMThttps://themulden.com/funds/pph/https://themulden.com/funds/pph/25 positions became 25: 0 added (0% of the fund), 0 dropped (0%). Turnover proxy 5.4%. Largest increases: Catalent Inc 1.92% to 2.91%; Perrigo Co PLC 2.15% to 2.72%; AmerisourceBergen Corp 4.32% to 4.88%; McKesson Corp 4.25% to 4.69%; Novo Nordisk A/S 4.98% to 5.42%; Eli Lilly & Co 4.79% to 5.16%. Largest decreases: Amarin Corp PLC 3.29% to 0.85%; Bausch Health Cos Inc 4.16% to 2.97%; Zoetis Inc 4.72% to 4.23%; Sanofi 5.01% to 4.58%; AbbVie Inc 5% to 4.68%; Jazz Pharmaceuticals PLC 3.24% to 2.93%. Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Fri, 22 May 2020 12:00:00 GMThttps://themulden.com/funds/pph/https://themulden.com/funds/pph/26 positions became 25: 0 added (0% of the fund), 1 dropped (0.14%). Turnover proxy 3.4%. Largest increases: Teva Pharmaceutical Industries Ltd 3.29% to 4.31%; Amarin Corp PLC 2.49% to 3.29%; Bausch Health Cos Inc 3.6% to 4.16%; Bristol-Myers Squibb Co 4.73% to 5.03%; Jazz Pharmaceuticals PLC 2.99% to 3.24%; Catalent Inc 1.77% to 1.92%. Largest decreases: AbbVie Inc 5.56% to 5%; Mylan NV 3.99% to 3.52%; Sanofi 5.43% to 5.01%; GlaxoSmithKline PLC 5.33% to 4.97%; GW Pharmaceuticals PLC 1.47% to 1.14%; Eli Lilly & Co 5.1% to 4.79%. Gone: DREYFUS GOVERNMENT CASH MANAGEMENT (0.14%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Tue, 25 Feb 2020 12:00:00 GMT